FDA cleared the Pleiades Device from My123Baby Medical Limited Dba Boost Fertility on Oct 30, 2026 under K262066, a traditional 510(k). The device falls under product code MQK, Labware, Assisted Reproduction, regulated at 21 CFR 884.6160 as a Class 2 device. The review panel was Obstetrics/Gynecology.

FDA logged the submission as received on Jun 22, 2026. The decision came 130 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.

This is the only decision on file for My123Baby Medical Limited Dba Boost Fertility in the last 12 months of the tracker.